{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:25:31Z","timestamp":1791804331912,"version":"4.3.4"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1038\/s41588-025-02377-x","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:03:00Z","timestamp":1760605380000},"page":"2644-2654","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Expanding the scope of non-invasive prenatal screening"],"prefix":"10.1038","volume":"57","author":[{"given":"Kate Elizabeth","family":"Stanley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8772-6845","authenticated-orcid":false,"given":"Bernard","family":"Thienpont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3071-1191","authenticated-orcid":false,"given":"Joris Robert","family":"Vermeesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"key":"2377_CR1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(66)91387-0","volume":"1","author":"MW Steele","year":"1966","unstructured":"Steele, M. W. & Breg, W. R. Chromosome analysis of human amniotic-fluid cells. Lancet 1, 383\u2013385 (1966).","journal-title":"Lancet"},{"key":"2377_CR2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1469-0705.1999.13040231.x","volume":"13","author":"K Spencer","year":"1999","unstructured":"Spencer, K., Souter, V., Tul, N., Snijders, R. & Nicolaides, K. H. A screening program for trisomy 21 at 10\u201314 weeks using fetal nuchal translucency, maternal serum free \u03b2-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet. Gynecol. 13, 231\u2013237 (1999).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2377_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(97)02174-0","volume":"350","author":"YM Lo","year":"1997","unstructured":"Lo, Y. M. et al. Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485\u2013487 (1997).","journal-title":"Lancet"},{"key":"2377_CR4","doi-asserted-by":"crossref","first-page":"16266","DOI":"10.1073\/pnas.0808319105","volume":"105","author":"HC Fan","year":"2008","unstructured":"Fan, H. C., Blumenfeld, Y. J., Chitkara, U., Hudgins, L. & Quake, S. R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl Acad. Sci. USA 105, 16266\u201316271 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2377_CR5","doi-asserted-by":"crossref","first-page":"20458","DOI":"10.1073\/pnas.0810641105","volume":"105","author":"RWK Chiu","year":"2008","unstructured":"Chiu, R. W. K. et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc. Natl Acad. Sci. USA 105, 20458\u201320463 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2377_CR6","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ajhg.2019.10.005","volume":"105","author":"KRM van der Meij","year":"2019","unstructured":"van der Meij, K. R. M. et al. TRIDENT-2: national implementation of genome-wide non-invasive prenatal testing as a first-tier screening test in the Netherlands. Am. J. Hum. Genet. 105, 1091\u20131101 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"2377_CR7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41436-021-01101-4","volume":"23","author":"K Van Den Bogaert","year":"2021","unstructured":"Van Den Bogaert, K. et al. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet. Med. 23, 1137\u20131142 (2021).","journal-title":"Genet. Med."},{"key":"2377_CR8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1373\/clinchem.2015.252502","volume":"62","author":"G Koumbaris","year":"2016","unstructured":"Koumbaris, G. et al. Cell-free DNA analysis of targeted genomic regions in maternal plasma for non-invasive prenatal testing of trisomy 21, trisomy 18, trisomy 13, and fetal sex. Clin. Chem. 62, 848\u2013855 (2016).","journal-title":"Clin. Chem."},{"key":"2377_CR9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJMc2311046","volume":"391","author":"L Lannoo","year":"2024","unstructured":"Lannoo, L. et al. Rare autosomal trisomies and adverse perinatal outcomes. N. Engl. J. Med. 391, 184\u2013185 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2377_CR10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/pd.5223","volume":"38","author":"N Brison","year":"2018","unstructured":"Brison, N. et al. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing. Prenat. Diagn. 38, 258\u2013266 (2018).","journal-title":"Prenat. Diagn."},{"key":"2377_CR11","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ajhg.2022.04.018","volume":"109","author":"L van Prooyen Schuurman","year":"2022","unstructured":"van Prooyen Schuurman, L. et al. Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: follow-up results of the TRIDENT-2 study. Am. J. Hum. Genet. 109, 1140\u20131152 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"2377_CR12","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41431-022-01147-1","volume":"30","author":"L Lannoo","year":"2022","unstructured":"Lannoo, L. et al. Rare autosomal trisomies detected by non-invasive prenatal testing: an overview of current knowledge. Eur. J. Hum. Genet. 30, 1323\u20131330 (2022).","journal-title":"Eur. J. Hum. Genet."},{"key":"2377_CR13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan1240","volume":"9","author":"MD Pertile","year":"2017","unstructured":"Pertile, M. D. et al. Rare autosomal trisomies, revealed by maternal plasma DNA sequencing, suggest increased risk of feto-placental disease. Sci. Transl. Med. 9, eaan1240 (2017).","journal-title":"Sci. Transl. Med."},{"key":"2377_CR14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/cge.13098","volume":"93","author":"K Martin","year":"2018","unstructured":"Martin, K. et al. Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions. Clin. Genet. 93, 293\u2013300 (2018).","journal-title":"Clin. Genet."},{"key":"2377_CR15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238245","volume":"15","author":"M Kucharik","year":"2020","unstructured":"Kucharik, M., et al. Non-invasive prenatal testing (NIPT) by low coverage genomic sequencing: detection limits of screened chromosomal microdeletions. PLoS ONE 15, e0238245 (2020).","journal-title":"PLoS ONE"},{"key":"2377_CR16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/uog.15754","volume":"47","author":"SJ Gross","year":"2016","unstructured":"Gross, S. J. et al. Clinical experience with single-nucleotide polymorphism-based non-invasive prenatal screening for 22q11.2 deletion syndrome. Ultrasound Obstet. Gynecol. 47, 177\u2013183 (2016).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2377_CR17","doi-asserted-by":"crossref","first-page":"368.e1","DOI":"10.1016\/j.ajog.2023.09.005","volume":"230","author":"LR Freud","year":"2024","unstructured":"Freud, L. R. et al. Prenatal vs postnatal diagnosis of 22q11.2 deletion syndrome: cardiac and noncardiac outcomes through 1 year of age. Am. J. Obstet. Gynecol. 230, 368.e1\u2013368.e12 (2024).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2377_CR18","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(00)02767-7","volume":"356","author":"H Saito","year":"2000","unstructured":"Saito, H., Sekizawa, A., Morimoto, T., Suzuki, M. & Yanaihara, T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356, 1170 (2000).","journal-title":"Lancet"},{"key":"2377_CR19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/clinchem\/46.2.301","volume":"46","author":"P Amicucci","year":"2000","unstructured":"Amicucci, P., Gennarelli, M., Novelli, G. & Dallapiccola, B. Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin. Chem. 46, 301\u2013302 (2000).","journal-title":"Clin. Chem."},{"key":"2377_CR20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/pd.6333","volume":"43","author":"J Shaw","year":"2023","unstructured":"Shaw, J. et al. Non-invasive fetal genotyping for maternal alleles with droplet digital PCR: a comparative study of analytical approaches. Prenat. Diagn. 43, 477\u2013488 (2023).","journal-title":"Prenat. Diagn."},{"key":"2377_CR21","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pd.5207","volume":"38","author":"EKL Chiu","year":"2018","unstructured":"Chiu, E. K. L., Hui, W. W. I. & Chiu, R. W. K. cfDNA screening and diagnosis of monogenic disorders \u2014 where are we heading? Prenat. Diagn. 38, 52\u201358 (2018).","journal-title":"Prenat. Diagn."},{"key":"2377_CR22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1042\/CS20210380","volume":"136","author":"B Hanson","year":"2022","unstructured":"Hanson, B., Scotchman, E., Chitty, L. S. & Chandler, N. J. Non-invasive prenatal diagnosis (NIPD): how analysis of cell-free DNA in maternal plasma has changed prenatal diagnosis for monogenic disorders. Clin. Sci. 136, 1615\u20131629 (2022).","journal-title":"Clin. Sci."},{"key":"2377_CR23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/pd.4124","volume":"33","author":"N Lench","year":"2013","unstructured":"Lench, N. et al. The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made. Prenat. Diagn. 33, 555\u2013562 (2013).","journal-title":"Prenat. Diagn."},{"key":"2377_CR24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41591-018-0334-x","volume":"25","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Non-invasive prenatal sequencing for multiple Mendelian monogenic disorders using circulating cell-free fetal DNA. Nat. Med. 25, 439\u2013447 (2019).","journal-title":"Nat. Med."},{"key":"2377_CR25","volume":"8","author":"C Xu","year":"2022","unstructured":"Xu, C., et al. Genetic deconvolution of fetal and maternal cell-free DNA in maternal plasma enables next-generation non-invasive prenatal screening. Cell Discov. 8, 109 (2022).","journal-title":"Cell Discov."},{"key":"2377_CR26","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41436-019-0748-y","volume":"22","author":"H Che","year":"2020","unstructured":"Che, H. et al. Noninvasive prenatal diagnosis by genome-wide haplotyping of cell-free plasma DNA. Genet. Med. 22, 962\u2013973 (2020).","journal-title":"Genet. Med."},{"key":"2377_CR27","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1056\/NEJMc2307918","volume":"389","author":"I Miceikait\u0117","year":"2023","unstructured":"Miceikait\u0117, I. et al. Comprehensive noninvasive fetal screening by deep trio-exome sequencing. N. Engl. J. Med. 389, 2017\u20132019 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2377_CR28","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMc2216144","volume":"389","author":"H Brand","year":"2023","unstructured":"Brand, H. et al. High-resolution and noninvasive fetal exome screening. N. Engl. J. Med. 389, 2014\u20132016 (2023).","journal-title":"N. Engl. J. Med."},{"key":"2377_CR29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1086\/301800","volume":"62","author":"YM Lo","year":"1998","unstructured":"Lo, Y. M. et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62, 768\u2013775 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"2377_CR30","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41592-025-02648-9","volume":"22","author":"AP Cheng","year":"2025","unstructured":"Cheng, A. P., et al. Error-corrected flow-based sequencing at whole-genome scale and its application to circulating cell-free DNA profiling. Nat. Methods 22, 973\u2013981 (2025).","journal-title":"Nat. Methods"},{"key":"2377_CR31","unstructured":"Belgian Society for Human Genetics. Prenatal testing https:\/\/beshg.be\/workgroups\/prenatal-testing (2023)."},{"key":"2377_CR32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114799","volume":"43","author":"J Linthorst","year":"2024","unstructured":"Linthorst, J., Nivard, M. & Sistermans, E. A. GWAS shows the genetics behind cell-free DNA and highlights the importance of p.Arg206Cys in DNASE1L3 for non-invasive testing. Cell Rep. 43, 114799 (2024).","journal-title":"Cell Rep."},{"key":"2377_CR33","volume":"4","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. Utilizing non-invasive prenatal test sequencing data for human genetic investigation. Cell Genom. 4, 100669 (2024).","journal-title":"Cell Genom."},{"key":"2377_CR34","volume":"6","author":"J Zeng","year":"2025","unstructured":"Zeng, J., et al. Protocol for genetic analysis of population-scale ultra-low-depth sequencing data. STAR Protoc. 6, 103579 (2025).","journal-title":"STAR Protoc."},{"key":"2377_CR35","volume":"2","author":"S Kim","year":"2024","unstructured":"Kim, S., et al. P761: Calculating maternal polygenic risk scores from prenatal screening by cell-free DNA data*. GIM Open 2, 101669 (2024).","journal-title":"GIM Open"},{"key":"2377_CR36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1161\/HYPERTENSIONAHA.123.21053","volume":"81","author":"VP Kovacheva","year":"2024","unstructured":"Kovacheva, V. P. et al. Preeclampsia prediction using machine learning and polygenic risk scores from clinical and genetic risk factors in early and late pregnancies. Hypertension 81, 264\u2013272 (2024).","journal-title":"Hypertension"},{"key":"2377_CR37","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/HJH.0000000000003336","volume":"41","author":"J Nurkkala","year":"2023","unstructured":"Nurkkala, J. et al. Associations of polygenic risk scores for preeclampsia and blood pressure with hypertensive disorders of pregnancy. J. Hypertens. 41, 380\u2013387 (2023).","journal-title":"J. Hypertens."},{"key":"2377_CR38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00125-023-06065-5","volume":"67","author":"J Zhen","year":"2024","unstructured":"Zhen, J. et al. Genome-wide association and Mendelian randomisation analysis among 30,699 Chinese pregnant women identifies novel genetic and molecular risk factors for gestational diabetes and glycaemic traits. Diabetologia 67, 703\u2013713 (2024).","journal-title":"Diabetologia"},{"key":"2377_CR39","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41588-024-01839-y","volume":"56","author":"D Westergaard","year":"2024","unstructured":"Westergaard, D. et al. Genome-wide association meta-analysis identifies five loci associated with postpartum hemorrhage. Nat. Genet. 56, 1597\u20131603 (2024).","journal-title":"Nat. Genet."},{"key":"2377_CR40","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1067\/S0002-9378(03)00537-4","volume":"189","author":"LH Smith","year":"2003","unstructured":"Smith, L. H., Danielsen, B., Allen, M. E. & Cress, R. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am. J. Obstet. Gynecol. 189, 1128\u20131135 (2003).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2377_CR41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1634\/theoncologist.2002-0279","volume":"7","author":"NA Pavlidis","year":"2002","unstructured":"Pavlidis, N. A. Coexistence of pregnancy and malignancy. Oncologist 7, 279\u2013287 (2002).","journal-title":"Oncologist"},{"key":"2377_CR42","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/OP.23.00594","volume":"20","author":"CJ Heesterbeek","year":"2024","unstructured":"Heesterbeek, C. J. et al. Comprehensive recommendations for the clinical management of pregnant women with noninvasive prenatal test results suspicious of a maternal malignancy. JCO Oncol. Pract. 20, 1027\u20131034 (2024).","journal-title":"JCO Oncol. Pract."},{"key":"2377_CR43","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100856","volume":"35","author":"L Lenaerts","year":"2021","unstructured":"Lenaerts, L., et al. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: a single-center retrospective analysis of over 85,000 pregnancies. EClinicalMedicine 35, 100856 (2021).","journal-title":"EClinicalMedicine"},{"key":"2377_CR44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","volume":"314","author":"DW Bianchi","year":"2015","unstructured":"Bianchi, D. W. et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 314, 162\u2013169 (2015).","journal-title":"JAMA"},{"key":"2377_CR45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1373\/clinchem.2017.277517","volume":"64","author":"NG Dharajiya","year":"2018","unstructured":"Dharajiya, N. G. et al. Incidental detection of maternal neoplasia in noninvasive prenatal testing. Clin. Chem. 64, 329\u2013335 (2018).","journal-title":"Clin. Chem."},{"key":"2377_CR46","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41436-019-0510-5","volume":"21","author":"X Ji","year":"2019","unstructured":"Ji, X. et al. Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests. Genet. Med. 21, 2293\u20132302 (2019).","journal-title":"Genet. Med."},{"key":"2377_CR47","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/AOG.0000000000005107","volume":"141","author":"G Goldring","year":"2023","unstructured":"Goldring, G. et al. Maternal malignancy after atypical findings on single-nucleotide polymorphism-based prenatal cell-free DNA screening. Obstet. Gynecol. 141, 791\u2013800 (2023).","journal-title":"Obstet. Gynecol."},{"key":"2377_CR48","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa2401029","volume":"391","author":"AE Turriff","year":"2024","unstructured":"Turriff, A. E. et al. Prenatal cfDNA sequencing and incidental detection of maternal cancer. N. Engl. J. Med. 391, 2123\u20132132 (2024).","journal-title":"N. Engl. J. Med."},{"key":"2377_CR49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/pd.5379","volume":"39","author":"P Benn","year":"2019","unstructured":"Benn, P., Plon, S. E. & Bianchi, D. W. Current controversies in prenatal diagnosis 2: NIPT results suggesting maternal cancer should always be disclosed. Prenat. Diagn. 39, 339\u2013343 (2019).","journal-title":"Prenat. Diagn."},{"key":"2377_CR50","volume":"372","author":"YMD Lo","year":"2021","unstructured":"Lo, Y. M. D., Han, D. S. C., Jiang, P. & Chiu, R. W. K. Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies. Science 372, eaaw3616 (2021).","journal-title":"Science"},{"key":"2377_CR51","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1093\/clinchem\/hvaa258","volume":"66","author":"RWK Chiu","year":"2020","unstructured":"Chiu, R. W. K., Heitzer, E., Lo, Y. M. D., Mouliere, F. & Tsui, D. W. Y. Cell-free DNA fragmentomics: the new \u2018omics\u2019 on the block. Clin. Chem. 66, 1480\u20131484 (2020).","journal-title":"Clin. Chem."},{"key":"2377_CR52","volume":"10","author":"P Ulz","year":"2019","unstructured":"Ulz, P. et al. Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nat. Commun. 10, 4666 (2019).","journal-title":"Nat. Commun."},{"key":"2377_CR53","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2015.11.050","volume":"164","author":"MW Snyder","year":"2016","unstructured":"Snyder, M. W., Kircher, M., Hill, A. J., Daza, R. M. & Shendure, J. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell 164, 57\u201368 (2016).","journal-title":"Cell"},{"key":"2377_CR54","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41587-022-01222-4","volume":"40","author":"MS Esfahani","year":"2022","unstructured":"Esfahani, M. S. et al. Inferring gene expression from cell-free DNA fragmentation profiles. Nat. Biotechnol. 40, 585\u2013597 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2377_CR55","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ng.3648","volume":"48","author":"P Ulz","year":"2016","unstructured":"Ulz, P. et al. Inferring expressed genes by whole-genome sequencing of plasma DNA. Nat. Genet. 48, 1273\u20131278 (2016).","journal-title":"Nat. Genet."},{"key":"2377_CR56","volume":"119","author":"Q Zhou","year":"2022","unstructured":"Zhou, Q. et al. Epigenetic analysis of cell-free DNA by fragmentomic profiling. Proc. Natl Acad. Sci. USA 119, e2209852119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2377_CR57","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-48466-z","volume":"15","author":"K De Ridder","year":"2024","unstructured":"De Ridder, K., Che, H., Leroy, K. & Thienpont, B. Benchmarking of methods for DNA methylome deconvolution. Nat. Commun. 15, 4134 (2024).","journal-title":"Nat. Commun."},{"key":"2377_CR58","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46435-0","volume":"15","author":"KE Stanley","year":"2024","unstructured":"Stanley, K. E. et al. Cell type signatures in cell-free DNA fragmentation profiles reveal disease biology. Nat. Commun. 15, 2220 (2024).","journal-title":"Nat. Commun."},{"key":"2377_CR59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41586-022-05580-6","volume":"613","author":"N Loyfer","year":"2023","unstructured":"Loyfer, N. et al. A DNA methylation atlas of normal human cell types. Nature 613, 355\u2013364 (2023).","journal-title":"Nature"},{"key":"2377_CR60","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.placenta.2013.11.014","volume":"35","author":"ES Taglauer","year":"2014","unstructured":"Taglauer, E. S., Wilkins-Haug, L. & Bianchi, D. W. Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta 35, S64\u2013S68 (2014).","journal-title":"Placenta"},{"key":"2377_CR61","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1373\/clinchem.2008.111385","volume":"54","author":"FMF Lun","year":"2008","unstructured":"Lun, F. M. F. et al. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin. Chem. 54, 1664\u20131672 (2008).","journal-title":"Clin. Chem."},{"key":"2377_CR62","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-015-0645-x","volume":"16","author":"TJ Jensen","year":"2015","unstructured":"Jensen, T. J. et al. Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains. Genome Biol. 16, 78 (2015).","journal-title":"Genome Biol."},{"key":"2377_CR63","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1373\/clinchem.2003.024893","volume":"50","author":"KCA Chan","year":"2004","unstructured":"Chan, K. C. A. et al. Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 50, 88\u201392 (2004).","journal-title":"Clin. Chem."},{"key":"2377_CR64","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-19-0622","volume":"10","author":"P Jiang","year":"2020","unstructured":"Jiang, P. et al. Plasma DNA end-motif profiling as a fragmentomic marker in cancer, pregnancy, and transplantation. Cancer Discov. 10, 664\u2013673 (2020).","journal-title":"Cancer Discov."},{"key":"2377_CR65","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41591-025-03509-w","volume":"31","author":"M Adil","year":"2025","unstructured":"Adil, M. et al. Preeclampsia risk prediction from prenatal cell-free DNA screening. Nat. Med. 31, 1312\u20131318 (2025).","journal-title":"Nat. Med."},{"key":"2377_CR66","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/pd.3892","volume":"32","author":"JA Canick","year":"2012","unstructured":"Canick, J. A. et al. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat. Diagn. 32, 730\u2013734 (2012).","journal-title":"Prenat. Diagn."},{"key":"2377_CR67","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/pd.4119","volume":"33","author":"E Wang","year":"2013","unstructured":"Wang, E. et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat. Diagn. 33, 662\u2013666 (2013).","journal-title":"Prenat. Diagn."},{"key":"2377_CR68","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-025-08834-1","volume":"641","author":"MC Nesselbush","year":"2025","unstructured":"Nesselbush, M. C., et al. An ultrasensitive method for detection of cell-free RNA. Nature 641, 759\u2013768 (2025).","journal-title":"Nature"},{"key":"2377_CR69","first-page":"241","volume":"142","author":"P Mandel","year":"1948","unstructured":"Mandel, P. & Metais, P. [Nuclear acids in human blood plasma]. C. R. Seances Soc. Biol. Fil. 142, 241\u2013243 (1948).","journal-title":"C. R. Seances Soc. Biol. Fil."},{"key":"2377_CR70","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/s41587-021-01188-9","volume":"40","author":"SK Vorperian","year":"2022","unstructured":"Vorperian, S. K., Moufarrej, M. N. & Quake, S. R. Cell types of origin of the cell-free transcriptome. Nat. Biotechnol. 40, 855\u2013861 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2377_CR71","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","volume":"209","author":"S Lisonkova","year":"2013","unstructured":"Lisonkova, S. & Joseph, K. S. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am. J. Obstet. Gynecol. 209, 544.e1\u2013544.e12 (2013).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2377_CR72","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/s41591-023-02510-5","volume":"29","author":"M De Borre","year":"2023","unstructured":"De Borre, M. et al. Cell-free DNA methylome analysis for early preeclampsia prediction. Nat. Med. 29, 2206\u20132215 (2023).","journal-title":"Nat. Med."},{"key":"2377_CR73","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/EDE.0000000000000213","volume":"26","author":"P Mendola","year":"2015","unstructured":"Mendola, P. et al. Controlled direct effects of preeclampsia on neonatal health after accounting for mediation by preterm birth. Epidemiology 26, 17\u201326 (2015).","journal-title":"Epidemiology"},{"key":"2377_CR74","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik, D. L. et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N. Engl. J. Med. 377, 613\u2013622 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2377_CR75","volume":"11","author":"Y Yu","year":"2024","unstructured":"Yu, Y., et al. Non-invasive prediction of preeclampsia using the maternal plasma cell-free DNA profile and clinical risk factors. Front. Med. 11, 1254467 (2024).","journal-title":"Front. Med."},{"key":"2377_CR76","doi-asserted-by":"crossref","first-page":"244.e1","DOI":"10.1016\/j.ajog.2023.12.008","volume":"231","author":"EC Becking","year":"2024","unstructured":"Becking, E. C. et al. Fetal fraction of cell-free DNA in noninvasive prenatal testing and adverse pregnancy outcomes: a nationwide retrospective cohort study of 56,110 pregnant women. Am. J. Obstet. Gynecol. 231, 244.e1\u2013244.e18 (2024).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2377_CR77","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41586-022-04410-z","volume":"602","author":"MN Moufarrej","year":"2022","unstructured":"Moufarrej, M. N. et al. Early prediction of preeclampsia in pregnancy with cell-free RNA. Nature 602, 689\u2013694 (2022).","journal-title":"Nature"},{"key":"2377_CR78","doi-asserted-by":"crossref","first-page":"553.e1","DOI":"10.1016\/j.ajog.2023.05.015","volume":"229","author":"S Zhou","year":"2023","unstructured":"Zhou, S. et al. Noninvasive preeclampsia prediction using plasma cell-free RNA signatures. Am. J. Obstet. Gynecol. 229, 553.e1\u2013553.e16 (2023).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2377_CR79","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/s41591-025-03509-w","volume":"31","author":"M Adil","year":"2025","unstructured":"Adil, M., et al. Preeclampsia risk prediction from prenatal cell-free DNA screening. Nat. Med. 31, 1312\u20131318 (2025).","journal-title":"Nat. Med."},{"key":"2377_CR80","doi-asserted-by":"crossref","first-page":"S973","DOI":"10.1016\/j.ajog.2020.10.025","volume":"226","author":"BA Bakrania","year":"2022","unstructured":"Bakrania, B. A., George, E. M. & Granger, J. P. Animal models of preeclampsia: investigating pathophysiology and therapeutic targets. Am. J. Obstet. Gynecol. 226, S973\u2013S987 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2377_CR81","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.ajog.2015.08.042","volume":"213","author":"SJ Fisher","year":"2015","unstructured":"Fisher, S. J. Why is placentation abnormal in preeclampsia?. Am. J. Obstet. Gynecol. 213, S115\u2013S122 (2015).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2377_CR82","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.bpobgyn.2014.08.004","volume":"29","author":"D Mitanchez","year":"2015","unstructured":"Mitanchez, D. et al. The offspring of the diabetic mother\u2014short- and long-term implications. Best Pract. Res. Clin. Obstet. Gynaecol. 29, 256\u2013269 (2015).","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"2377_CR83","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.metabol.2018.03.025","volume":"86","author":"E Kintiraki","year":"2018","unstructured":"Kintiraki, E. & Goulis, D. G. Gestational diabetes mellitus: multi-disciplinary treatment approaches. Metabolism 86, 91\u2013101 (2018).","journal-title":"Metabolism"},{"key":"2377_CR84","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrendo.2012.96","volume":"8","author":"TA Buchanan","year":"2012","unstructured":"Buchanan, T. A., Xiang, A. H. & Page, K. A. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat. Rev. Endocrinol. 8, 639\u2013649 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2377_CR85","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","volume":"373","author":"L Bellamy","year":"2009","unstructured":"Bellamy, L., Casas, J.-P., Hingorani, A. D. & Williams, D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373, 1773\u20131779 (2009).","journal-title":"Lancet"},{"key":"2377_CR86","volume":"34","author":"J Hu","year":"2021","unstructured":"Hu, J., et al. Association of maternal lipid profile and gestational diabetes mellitus: a systematic review and meta-analysis of 292 studies and 97,880 women. EClinicalMedicine 34, 100830 (2021).","journal-title":"EClinicalMedicine"},{"key":"2377_CR87","volume":"2","author":"EA Huhn","year":"2023","unstructured":"Huhn, E. A. et al. Sensitivity, specificity, and diagnostic accuracy of WHO 2013 criteria for diagnosis of gestational diabetes mellitus in low risk early pregnancies: international, prospective, multicentre cohort study. BMJ Med. 2, e000330 (2023).","journal-title":"BMJ Med."},{"key":"2377_CR88","volume":"5","author":"Z Tang","year":"2024","unstructured":"Tang, Z., et al. Longitudinal integrative cell-free DNA analysis in gestational diabetes mellitus. Cell Rep. Med. 5, 101660 (2024).","journal-title":"Cell Rep. Med."},{"key":"2377_CR89","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/EJE-19-0117","volume":"180","author":"K Benhalima","year":"2019","unstructured":"Benhalima, K. et al. Risk factor screening for gestational diabetes mellitus based on the 2013 WHO criteria. Eur. J. Endocrinol. 180, 353\u2013363 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"2377_CR90","doi-asserted-by":"crossref","first-page":"102435","DOI":"10.1016\/j.eclinm.2024.102435","volume":"68","author":"YM Hwang","year":"2024","unstructured":"Hwang, Y. M. et al. Maternal\u2013fetal outcomes in patients with immune mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system. EClinicalMedicine 68, 102435 (2024).","journal-title":"EClinicalMedicine"},{"key":"2377_CR91","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1753495X20964680","volume":"14","author":"JR Lim","year":"2021","unstructured":"Lim, J. R. et al. Prevalence of autoimmune conditions in pregnant women in a tertiary maternity hospital: a cross-sectional survey and maternity database review. Obstet. Med. 14, 158\u2013163 (2021).","journal-title":"Obstet. Med."},{"key":"2377_CR92","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/0961203316686704","volume":"26","author":"S Wei","year":"2017","unstructured":"Wei, S., Lai, K., Yang, Z. & Zeng, K. Systemic lupus erythematosus and risk of preterm birth: a systematic review and meta-analysis of observational studies. Lupus 26, 563\u2013571 (2017).","journal-title":"Lupus"},{"key":"2377_CR93","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2021.12.245","volume":"162","author":"B Verstockt","year":"2022","unstructured":"Verstockt, B., Parkes, M. & Lee, J. C. How do we predict a patient\u2019s disease course and whether they will respond to specific treatments? Gastroenterology 162, 1383\u20131395 (2022).","journal-title":"Gastroenterology"},{"key":"2377_CR94","volume":"7","author":"H Che","year":"2022","unstructured":"Che, H., et al. Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets. NPJ Genom. Med. 7, 55 (2022).","journal-title":"NPJ Genom. Med."},{"key":"2377_CR95","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2021.100466","volume":"3","author":"HJ Mackinnon","year":"2021","unstructured":"Mackinnon, H. J. et al. Impact of maternal autoimmune disease on cell-free DNA test characteristics. Am. J. Obstet. Gynecol. MFM 3, 100466 (2021).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"2377_CR96","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman, D. D., Iba\u00f1ez, D. & Urowitz, M. B. Systemic lupus erythematosus disease activity index 2000. J. Rheumatol. 29, 288\u2013291 (2002).","journal-title":"J. Rheumatol."},{"key":"2377_CR97","volume":"120","author":"Z Zhou","year":"2023","unstructured":"Zhou, Z. et al. Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs. Proc. Natl Acad. Sci. USA 120, e2220982120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2377_CR98","volume":"7","author":"H Che","year":"2022","unstructured":"Che, H. et al. Machine learning-based detection of immune-mediated diseases from genome-wide cell-free DNA sequencing datasets. NPJ Genom. Med. 7, 55 (2022).","journal-title":"NPJ Genom. Med."},{"key":"2377_CR99","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","volume":"402","author":"EO Ohuma","year":"2023","unstructured":"Ohuma, E. O. et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis. Lancet 402, 1261\u20131271 (2023).","journal-title":"Lancet"},{"key":"2377_CR100","unstructured":"World Health Organization. WHO recommendations on interventions to improve preterm birth outcomes. https:\/\/www.who.int\/publications\/i\/item\/9789241508988 (2015)."},{"key":"2377_CR101","unstructured":"World Health Organization. WHO recommendation on tocolytic therapy for improving preterm birth outcomes. https:\/\/www.who.int\/publications\/i\/item\/9789240057227 (2022)."},{"key":"2377_CR102","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/REP-17-0619","volume":"155","author":"SR van Boeckel","year":"2018","unstructured":"van Boeckel, S. R., Davidson, D. J., Norman, J. E. & Stock, S. J. Cell-free fetal DNA and spontaneous preterm birth. Reproduction 155, R137\u2013R145 (2018).","journal-title":"Reproduction"},{"key":"2377_CR103","doi-asserted-by":"crossref","first-page":"72.e1","DOI":"10.1016\/j.ajog.2022.04.002","volume":"227","author":"J Camunas-Soler","year":"2022","unstructured":"Camunas-Soler, J. et al. Predictive RNA profiles for early and very early spontaneous preterm birth. Am. J. Obstet. Gynecol. 227, 72.e1\u201372.e16 (2022).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2377_CR104","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1126\/science.aar3819","volume":"360","author":"TTM Ngo","year":"2018","unstructured":"Ngo, T. T. M. et al. Noninvasive blood tests for fetal development predict gestational age and preterm delivery. Science 360, 1133\u20131136 (2018).","journal-title":"Science"},{"key":"2377_CR105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/FM9.0000000000000133","volume":"4","author":"W Yu","year":"2021","unstructured":"Yu, W., Hu, X. & Cao, B. Viral infections during pregnancy: the big challenge threatening maternal and fetal health. Matern. Fetal Med. 4, 72\u201386 (2021).","journal-title":"Matern. Fetal Med."},{"key":"2377_CR106","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/pd.6116","volume":"43","author":"J Linthorst","year":"2023","unstructured":"Linthorst, J., Welkers, M. R. A. & Sistermans, E. A. Clinically relevant DNA viruses in pregnancy. Prenat. Diagn. 43, 457\u2013466 (2023).","journal-title":"Prenat. Diagn."},{"key":"2377_CR107","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/cid\/cix344","volume":"65","author":"GSA Smit","year":"2017","unstructured":"Smit, G. S. A. et al. Public health impact of congenital toxoplasmosis and cytomegalovirus infection in Belgium, 2013: a systematic review and data synthesis. Clin. Infect. Dis. 65, 661\u2013668 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"2377_CR108","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/uog.26136","volume":"61","author":"F D\u2019Antonio","year":"2023","unstructured":"D\u2019Antonio, F., Marinceu, D., Prasad, S. & Khalil, A. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis. Ultrasound Obstet. Gynecol. 61, 436\u2013444 (2023).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2377_CR109","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","volume":"396","author":"K Shahar-Nissan","year":"2020","unstructured":"Shahar-Nissan, K. et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet 396, 779\u2013785 (2020).","journal-title":"Lancet"},{"key":"2377_CR110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cell.2018.08.016","volume":"175","author":"S Liu","year":"2018","unstructured":"Liu, S. et al. Genomic analyses from non-invasive prenatal testing reveal genetic associations, patterns of viral infections, and Chinese population history. Cell 175, 347\u2013359 (2018).","journal-title":"Cell"},{"key":"2377_CR111","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/pd.6143","volume":"43","author":"J Linthorst","year":"2023","unstructured":"Linthorst, J., Baksi, M. M. M., Welkers, M. R. A. & Sistermans, E. A. The cell-free DNA virome of 108,349 Dutch pregnant women. Prenat. Diagn. 43, 448\u2013456 (2023).","journal-title":"Prenat. Diagn."},{"key":"2377_CR112","first-page":"228","volume":"2","author":"J Linthorst","year":"2021","unstructured":"Linthorst, J., Welkers, M. R. A. & Sistermans, E. A. Distinct fragmentation patterns of circulating viral cell-free DNA in 83,552 non-invasive prenatal testing samples. Extracell. Vesicles Circ. Nucl. Acids 2, 228\u2013237 (2021).","journal-title":"Extracell. Vesicles Circ. Nucl. Acids"},{"key":"2377_CR113","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/uog.29199","volume":"65","author":"BHW Faas","year":"2025","unstructured":"Faas, B. H. W. et al. Detection of human cytomegalovirus cell-free DNA in pregnant women with symptomatically infected fetuses: proof-of-concept study. Ultrasound Obstet. Gynecol. 65, 470\u2013477 (2025).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2377_CR114","volume":"100","author":"BHW Faas","year":"2024","unstructured":"Faas, B. H. W. et al. Early detection of active human cytomegalovirus (hCMV) infection in pregnant women using data generated for noninvasive fetal aneuploidy testing. EBioMedicine 100, 104983 (2024).","journal-title":"EBioMedicine"},{"key":"2377_CR115","volume":"13","author":"A Passemiers","year":"2024","unstructured":"Passemiers, A., et al. Alleviating cell-free DNA sequencing biases with optimal transport. eLife 13, RP98116 (2024).","journal-title":"eLife"},{"key":"2377_CR116","doi-asserted-by":"crossref","DOI":"10.11604\/pamj-oh.2023.11.1.39297","volume":"11","author":"B Jikamo","year":"2023","unstructured":"Jikamo, B., Adefris, M., Azale, T. & Alemu, K. Incidence, trends and risk factors of preeclampsia in sub-Saharan Africa: a systematic review and meta-analysis. PAMJ One Health 11, 1 (2023).","journal-title":"PAMJ One Health"},{"key":"2377_CR117","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1016\/S2214-109X(24)00560-6","volume":"13","author":"JA Cresswell","year":"2025","unstructured":"Cresswell, J. A. et al. Global and regional causes of maternal deaths 2009\u201320: a WHO systematic analysis. Lancet Glob. Health 13, e626\u2013e634 (2025).","journal-title":"Lancet Glob. Health"},{"key":"2377_CR118","unstructured":"World Health Organization. Born too soon: decade of action on preterm birth. https:\/\/www.who.int\/publications\/i\/item\/9789240073890 (2023)."},{"key":"2377_CR119","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ogc.2021.02.002","volume":"48","author":"SE Damhuis","year":"2021","unstructured":"Damhuis, S. E., Ganzevoort, W. & Gordijn, S. J. Abnormal fetal growth: small for gestational age, fetal growth restriction, large for gestational age: definitions and epidemiology. Obstet. Gynecol. Clin. North Am. 48, 267\u2013279 (2021).","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"2377_CR120","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108642","volume":"172","author":"M Saeedi","year":"2021","unstructured":"Saeedi, M., Cao, Y., Fadl, H., Gustafson, H. & Simmons, D. Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: a systematic review and meta-analysis. Diabetes Res. Clin. Pract. 172, 108642 (2021).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2377_CR121","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/pd.6329","volume":"43","author":"L Lannoo","year":"2023","unstructured":"Lannoo, L. et al. A cross-country comparison of pregnant women\u2019s decision-making and perspectives when opting for non-invasive prenatal testing in the Netherlands and Belgium. Prenat. Diagn. 43, 294\u2013303 (2023).","journal-title":"Prenat. Diagn."},{"key":"2377_CR122","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41431-023-01504-8","volume":"32","author":"IM Bakkeren","year":"2024","unstructured":"Bakkeren, I. M. et al. Psychological impact of additional findings detected by genome-wide non-invasive prenatal testing (NIPT): TRIDENT-2 study. Eur. J. Hum. Genet. 32, 302\u2013308 (2024).","journal-title":"Eur. J. Hum. Genet."},{"key":"2377_CR123","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/pd.6357","volume":"43","author":"L Hui","year":"2023","unstructured":"Hui, L. et al. Position statement from the International Society for Prenatal Diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies. Prenat. Diagn. 43, 814\u2013828 (2023).","journal-title":"Prenat. Diagn."},{"key":"2377_CR124","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1101\/gr.278556.123","volume":"34","author":"H Che","year":"2024","unstructured":"Che, H. et al. Genomic origin, fragmentomics, and transcriptional properties of long cell-free DNA molecules in human plasma. Genome Res. 34, 189\u2013200 (2024).","journal-title":"Genome Res."},{"key":"2377_CR125","doi-asserted-by":"crossref","first-page":"E5503","DOI":"10.1073\/pnas.1422986112","volume":"112","author":"K Sun","year":"2015","unstructured":"Sun, K. et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl Acad. Sci. USA 112, E5503\u2013E5512 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2377_CR126","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/clinchem\/hvac180","volume":"69","author":"SCY Yu","year":"2023","unstructured":"Yu, S. C. Y. et al. Comparison of single molecule, real-time sequencing and nanopore sequencing for analysis of the size, end-motif, and tissue-of-origin of long cell-free DNA in plasma. Clin. Chem. 69, 168\u2013179 (2023).","journal-title":"Clin. Chem."},{"key":"2377_CR127","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/cr.2017.106","volume":"27","author":"C-X Song","year":"2017","unstructured":"Song, C.-X. et al. 5-hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell Res. 27, 1231\u20131242 (2017).","journal-title":"Cell Res."},{"key":"2377_CR128","doi-asserted-by":"crossref","DOI":"10.1038\/srep27859","volume":"6","author":"P Burnham","year":"2016","unstructured":"Burnham, P. et al. Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma. Sci. Rep. 6, 27859 (2016).","journal-title":"Sci. Rep."},{"key":"2377_CR129","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41587-020-00775-6","volume":"39","author":"R Sadeh","year":"2021","unstructured":"Sadeh, R. et al. ChIP\u2013seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin. Nat. Biotechnol. 39, 586\u2013598 (2021).","journal-title":"Nat. Biotechnol."},{"key":"2377_CR130","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1742-4658.2008.06849.x","volume":"276","author":"M Napirei","year":"2009","unstructured":"Napirei, M., Ludwig, S., Mezrhab, J., Kl\u00f6ckl, T. & Mannherz, H. G. Murine serum nucleases\u2014contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J. 276, 1059\u20131073 (2009).","journal-title":"FEBS J."},{"key":"2377_CR131","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1373\/clinchem.2011.169318","volume":"58","author":"YWL Zheng","year":"2012","unstructured":"Zheng, Y. W. L. et al. Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: a transplantation model. Clin. Chem. 58, 549\u2013558 (2012).","journal-title":"Clin. Chem."},{"key":"2377_CR132","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110742","volume":"27","author":"N Moldovan","year":"2024","unstructured":"Moldovan, N. et al. Comparison of cell-free and small extracellular-vesicle-associated DNA by sequencing plasma of lung cancer patients. iScience 27, 110742 (2024).","journal-title":"iScience"},{"key":"2377_CR133","volume":"14","author":"Y An","year":"2023","unstructured":"An, Y. et al. DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation. Nat. Commun. 14, 287 (2023).","journal-title":"Nat. Commun."},{"key":"2377_CR134","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.tig.2021.04.005","volume":"37","author":"DSC Han","year":"2021","unstructured":"Han, D. S. C. & Lo, Y. M. D. The nexus of cfDNA and nuclease biology. Trends Genet. 37, 758\u2013770 (2021).","journal-title":"Trends Genet."},{"key":"2377_CR135","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1101\/gr.275426.121","volume":"31","author":"DSC Han","year":"2021","unstructured":"Han, D. S. C. et al. Nuclease deficiencies alter plasma cell-free DNA methylation profiles. Genome Res. 31, 2008\u20132021 (2021).","journal-title":"Genome Res."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02377-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02377-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T23:03:49Z","timestamp":1762729429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-025-02377-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":135,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1038\/s41588-025-02377-x","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Patents related to cfDNA analyses are held by J.R.V. (PCT\/EP2018\/062615 and PCT\/EP2024\/065927) and B.T. (PCT\/EP2022\/056679 and PCT\/EP2025\/062611). K.E.S. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}